These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20246401)

  • 1. [Treatment of kala-azar with a new stoibi compound; 2.168 R. P. (First Results)].
    DURAND P; BENMUSSA S; CARUANA M
    Bull Mem Soc Med Hop Paris; 1946 Jul 5-12; 62(24-25):399-409. PubMed ID: 20246401
    [No Abstract]   [Full Text] [Related]  

  • 2. A new sodium antimony gluconate for the treatment of kala-azar.
    DASTIDAR SK
    J Indian Med Assoc; 1945 Sep; 14():298. PubMed ID: 21003768
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on the treatment of 25 cases of kala-azar with stibatin (sodium antimony gluconate).
    CHOUDHURI RK
    Ind Med Gaz; 1946; 81(4-5):174-6. PubMed ID: 20291436
    [No Abstract]   [Full Text] [Related]  

  • 4. Agranulocytosis following antimony therapy in kala-azar.
    BRAHMACHARI PN; MAITI CR; KAR CC
    J Indian Med Assoc; 1955 Oct; 25(10):408-10. PubMed ID: 13278551
    [No Abstract]   [Full Text] [Related]  

  • 5. [New contributions to the treatment of infantile kala-azar by antimony hexonate in oily and concentrated solution].
    FERNANDEZ CASTANYS A
    Rev Sanid; 1945 Feb; 19():114-24. PubMed ID: 21018391
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-Kala-Azar dermal leishmaniasis; a report of two typical cases with special reference to result of intensive antimonial therapy.
    TZU-TA C; PANG-MU C; LEE-SHIH L
    Chin Med J; 1953; 71(5):334-42. PubMed ID: 13127100
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 8. On the toxicity of some organic antimonial drugs used for the treatment of kala-azar.
    BOSE AN; GHOSH TN
    Ind Med Gaz; 1946 Jan; 81(1):13-6. PubMed ID: 21025569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
    GIRAUD P; BERNARD R; VINCENT P
    Arch Fr Pediatr; 1954; 11(6):659-62. PubMed ID: 13198287
    [No Abstract]   [Full Text] [Related]  

  • 10. [New Contributions To the Chemotherapy Of Infantile Kala-Azar By Concentrated Solustibosan].
    LOZANO MORALES A
    Rev Sanid; 1945 Aug; 19():529-35. PubMed ID: 21013091
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of kala-azar treated with a new antimony].
    NAUSSAC ; PELLERAT ; GONNET L
    Lyon Med; 1947 May; 177(20):334-9. PubMed ID: 20268746
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sodium antimony gluconate in mass treatment of kala-azar by the rate of disappearance of Leishman-Donovan bodies.
    HO EA; TAO CY; SUNG SJ
    Chin Med J; 1952; 70(5-6):243-52. PubMed ID: 13127087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience in the treatment of kala-azar].
    de YTURRIAGA E; GONZALEZ BOTELLA S
    Acta Pediatr Esp; 1950 May; 8(89):569-76. PubMed ID: 15418997
    [No Abstract]   [Full Text] [Related]  

  • 16. KALA AZAR IN LEBANON. REVIEW OF 72 CASES.
    BITAR J; NACHMAN H
    J Med Liban; 1964; 17():257-68. PubMed ID: 14252819
    [No Abstract]   [Full Text] [Related]  

  • 17. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
    Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three observations of kala azar cured by glucantime (2168-RP)].
    LEBON J; FABREGOULE M; AMOROS F
    Cah Med Union Fr; 1948 Dec; 3(25):761-6. PubMed ID: 18112444
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
    Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
    Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.